FDA Inspection 1095940 — LifeShare Blood Center
The FDA completed an inspection of LifeShare Blood Center on December 13, 2018 in Alexandria, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 13, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Alexandria, LA (United States)